ArticleBlood science (Baltimore, Md.)2026

Systemic high-dose MTX and BTK inhibitors in vitreoretinal lymphoma: efficacy and survival analysis.

Jing Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.